Showing results (2821-2830 of 8,036) with videos related to
Sort By:
Pageof 804
Current Medicinal Chemistry|December 17, 2011
Using feature selection technique for drug-target interaction networks predictionW Yu, Z Jiang, J Wang, et al.Current Medicinal Chemistry|February 7, 2012
GCPII variants, paralogs and orthologsK Hlouchová, V Navrátil, J Tykvart, et al.Current Medicinal Chemistry|February 7, 2012
The role of glutamate signaling in pain processes and its regulation by GCP II inhibitionK M Wozniak, C Rojas, Y Wu, et al.Current Medicinal Chemistry|February 7, 2012
NAAG, NMDA receptor and psychosisRichard Bergeron, Joseph T CoyleCurrent Medicinal Chemistry|February 4, 2012
Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related peptide in capsaicin afferentsY TacheCurrent Medicinal Chemistry|February 4, 2012
Novel concept in the mechanism of injury and protection of gastric mucosa: role of renin-angiotensin system and active metabolites of angiotensinT Brzozowski, A Ptak-Belowska, S Kwiecien, et al.Current Medicinal Chemistry|February 4, 2012
Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healingA Ahluwalia, A S TarnawskiCurrent Medicinal Chemistry|February 11, 2012
Dihydro-alkoxyl-benzyl-oxopyrimidine derivatives (DABOs) as non-nucleoside reverse transcriptase inhibitors: an update review (2001-2011)Shiqiong Yang, Fen-Er Chen, Erik De ClercqCurrent Medicinal Chemistry|March 21, 2012
Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspectsL Szalardy, P Klivenyi, D Zadori, et al.Current Medicinal Chemistry|March 21, 2012
Recent advances in the research of 2,3-diaryl-1,3-thiazolidin-4-one derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitorsYe Tian, Peng Zhan, Diwakar Rai, et al.Pageof 804